{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:28:52Z","timestamp":1792024132258,"version":"4.4.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31471208"],"award-info":[{"award-number":["31471208"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31671195"],"award-info":[{"award-number":["31671195"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31871381"],"award-info":[{"award-number":["31871381"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2014CFA021"],"award-info":[{"award-number":["2014CFA021"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Front Youth Program of HUST"},{"name":"Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, HUST"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.bbadis.2018.10.003","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T18:49:05Z","timestamp":1538506145000},"page":"3714-3725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["C-terminal truncation exacerbates the aggregation and cytotoxicity of \u03b1-Synuclein: A vicious cycle in Parkinson's disease"],"prefix":"10.1016","volume":"1864","author":[{"given":"Liang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2018.10.003_bb0005","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson's disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2018.10.003_bb0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","article-title":"The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia","volume":"120","author":"Schulz-Schaeffer","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0015","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2018.10.003_bb0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cell.2005.10.017","article-title":"Snaring the function of alpha-synuclein","volume":"123","author":"Bonini","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.10.003_bb0025","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3233\/JAD-2004-6412","article-title":"Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein","volume":"6","author":"Alim","year":"2004","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainres.2007.07.027","article-title":"An investigation into the lipid-binding properties of alpha-, beta- and gamma-synucleins in human brain and cerebrospinal fluid","volume":"1170","author":"Salem","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0035","doi-asserted-by":"crossref","first-page":"22670","DOI":"10.1074\/jbc.M501508200","article-title":"A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease","volume":"280","author":"Liu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0040","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1073\/pnas.0406976102","article-title":"Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0045","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/brb3.86","article-title":"Role of C-terminal negative charges and tyrosine residues in fibril formation of alpha-synuclein","volume":"2","author":"Izawa","year":"2012","journal-title":"Brain Behav."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0050","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nsmb.3433","article-title":"Asparagine endopeptidase cleaves alpha-synuclein and mediates pathologic activities in Parkinson's disease","volume":"24","author":"Zhang","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"34","key":"10.1016\/j.bbadis.2018.10.003_bb0055","first-page":"1","article-title":"Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons","volume":"4","author":"Daher","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0060","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1750-3639.2012.00597.x","article-title":"Critical role of truncated alpha-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease","volume":"22","author":"Prasad","year":"2012","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0065","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1146\/annurev-med-050715-104343","article-title":"Innate immunity and neurodegeneration","volume":"69","author":"Labzin","year":"2018","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0070","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuron.2009.08.039","article-title":"Immune activation in brain aging and neurodegeneration: too much or too little?","volume":"64","author":"Lucin","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2018.10.003_bb0075","article-title":"MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration","author":"Lee","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0080","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0085","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2016.03.046","article-title":"Inflammasome complexes: emerging mechanisms and effector functions","volume":"165","author":"Rathinam","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.10.003_bb0090","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","article-title":"Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0095","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s12035-017-0467-9","article-title":"NLRP3 inflammasome inhibitor ameliorates amyloid pathology in a mouse model of Alzheimer's disease","volume":"55","author":"Yin","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0100","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.1073\/pnas.1610099113","article-title":"Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein alpha-synuclein","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0105","doi-asserted-by":"crossref","first-page":"9958","DOI":"10.1073\/pnas.1610993113","article-title":"Caspase-1 clipping causes complications for alpha-synuclein","volume":"113","author":"Nuber","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0110","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1039\/C5FO00664C","article-title":"Inhibition effects of tanshinone on the aggregation of alpha-synuclein","volume":"7","author":"Ji","year":"2016","journal-title":"Food Funct."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0115","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/35081095","article-title":"Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding","volume":"411","author":"Saborio","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2018.10.003_bb0120","article-title":"Inhibitory effects of magnolol and honokiol on human calcitonin aggregation","volume":"5","author":"Guo","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0125","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/j.bbagen.2018.07.019","article-title":"Menadione sodium bisulfite inhibits the toxic aggregation of amyloid-beta(1-42)","volume":"1862","author":"Zhang","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2018.10.003_bb0130","doi-asserted-by":"crossref","first-page":"E1994","DOI":"10.1073\/pnas.1421204112","article-title":"Structural characterization of toxic oligomers that are kinetically trapped during alpha-synuclein fibril formation","volume":"112","author":"Chen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0135","doi-asserted-by":"crossref","first-page":"10278","DOI":"10.1021\/bi060879g","article-title":"Structure-specific effects of protein topology on cross-beta assembly: studies of insulin fibrillation","volume":"45","author":"Huang","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2018.10.003_bb0140","article-title":"Bisphenol A accelerates toxic amyloid formation of human islet amyloid polypeptide: a possible link between bisphenol A exposure and type 2 diabetes","volume":"8","author":"Gong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2018.10.003_bb0145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbapap.2005.07.008","article-title":"FT-IR approaches on amyloid fibril structure","volume":"1753","author":"Hiramatsu","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2018.10.003_bb0150","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bbrc.2013.09.032","article-title":"The effect of exposing a critical hydrophobic patch on amyloidogenicity and fibril structure of insulin","volume":"440","author":"Li","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0155","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/prot.24216","article-title":"Salvianolic acid B inhibits the amyloid formation of human islet amyloid polypeptide and protects pancreatic beta-cells against cytotoxicity","volume":"81","author":"Cheng","year":"2013","journal-title":"Proteins"},{"key":"10.1016\/j.bbadis.2018.10.003_bb0160","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.fct.2013.02.049","article-title":"Proanthocyanidins are the major anti-diabetic components of cinnamon water extract","volume":"56","author":"Jiao","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0165","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1096\/fj.14-265801","article-title":"Overexpression of glyceraldehyde 3-phosphate dehydrogenase prevents neurovascular degeneration after retinal injury","volume":"29","author":"Cai","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0170","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/brain\/aww028","article-title":"The heat shock response plays an important role in TDP-43 clearance: evidence for dysfunction in amyotrophic lateral sclerosis","volume":"139","author":"Chen","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2018.10.003_bb0175","doi-asserted-by":"crossref","first-page":"40732","DOI":"10.1074\/jbc.M110.141952","article-title":"Phosphorylated alpha-synuclein at Ser-129 is targeted to the proteasome pathway in a ubiquitin-independent manner","volume":"285","author":"Machiya","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0180","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00401-018-1892-1","article-title":"Synapsin III deficiency hampers alpha-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease","volume":"136","author":"Faustini","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0185","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/15548627.2017.1293768","article-title":"Histone HIST1H1C\/H1.2 regulates autophagy in the development of diabetic retinopathy","volume":"13","author":"Wang","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2018.10.003_bb0190","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1681\/ASN.2016111210","article-title":"ELABELA and an ELABELA fragment protect against AKI","volume":"28","author":"Chen","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0195","doi-asserted-by":"crossref","first-page":"19279","DOI":"10.1073\/pnas.1305517110","article-title":"Islet amyloid polypeptide toxicity and membrane interactions","volume":"110","author":"Cao","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0200","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1021\/ja809002a","article-title":"Induction of negative curvature as a mechanism of cell toxicity by amyloidogenic peptides: the case of islet amyloid polypeptide","volume":"131","author":"Smith","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0205","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/ar200189b","article-title":"Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective","volume":"45","author":"Brender","year":"2012","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0210","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.bbamem.2018.02.013","article-title":"Interaction between amyloidogenic proteins and biomembranes in protein misfolding diseases: mechanisms, contributors, and therapy","volume":"1680","author":"Cheng","year":"2018","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0215","doi-asserted-by":"crossref","first-page":"E2634","DOI":"10.1073\/pnas.1713849115","article-title":"Identification of a highly neurotoxic alpha-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease","volume":"115","author":"Grassi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0220","doi-asserted-by":"crossref","first-page":"15194","DOI":"10.1074\/jbc.M113.457408","article-title":"Lewy body-like alpha-synuclein aggregates resist degradation and impair macroautophagy","volume":"288","author":"Tanik","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0225","first-page":"303","article-title":"Best practices for generating and using alpha-synuclein pre-formed fibrils to model Parkinson's disease in rodents","volume":"8","author":"Polinski","year":"2018","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0230","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0235","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1074\/jbc.M310994200","article-title":"Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective","volume":"279","author":"Tanaka","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0240","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.jmb.2014.02.024","article-title":"Sequence and membrane determinants of the random coil-helix transition of alpha-synuclein","volume":"426","author":"Lokappa","year":"2014","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0245","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nchembio.1750","article-title":"Lipid vesicles trigger alpha-synuclein aggregation by stimulating primary nucleation","volume":"11","author":"Galvagnion","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0250","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1039\/C3CS60431D","article-title":"Differences between amyloid-beta aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease","volume":"43","author":"Kotler","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0255","doi-asserted-by":"crossref","first-page":"16547","DOI":"10.1074\/jbc.M110629200","article-title":"The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c","volume":"277","author":"Karpinich","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0260","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00401-011-0921-0","article-title":"Neurodegeneration as a consequence of failed mitochondrial maintenance","volume":"123","author":"Karbowski","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0265","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cell.2014.12.019","article-title":"Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration","volume":"160","author":"Liu","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.10.003_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"Alpha-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0275","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0280","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0285","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease","volume":"10","author":"Philips","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0290","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","article-title":"The choreography of neuroinflammation in Huntington's disease","volume":"36","author":"Crotti","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0295","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/mds.25143","article-title":"Head injury and Parkinson's disease: a population-based study","volume":"27","author":"Fang","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0300","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1212\/01.wnl.0000311269.57716.63","article-title":"Protective effects of NSAIDs on the development of Alzheimer disease","volume":"70","author":"Vlad","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2018.10.003_bb0305","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1212\/WNL.0b013e31820f2d79","article-title":"Use of ibuprofen and risk of Parkinson disease","volume":"76","author":"Gao","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2018.10.003_bb0310","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0315","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"20","key":"10.1016\/j.bbadis.2018.10.003_bb0320","first-page":"1","article-title":"The inhibitory effect of pyrroloquinoline quinone on the amyloid formation and cytotoxicity of truncated alpha-synuclein","volume":"5","author":"Kim","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0325","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1021\/bi027363r","article-title":"Role of alpha-synuclein carboxy-terminus on fibril formation in vitro","volume":"42","author":"Murray","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2018.10.003_bb0330","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0335","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia"},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2018.10.003_bb0340","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S1353-8020(11)70008-6","article-title":"Misfolded alpha-synuclein and Toll-like receptors: therapeutic targets for Parkinson's disease","volume":"18","author":"Beraud","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0345","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1093\/brain\/awx284","article-title":"Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-beta42 in Alzheimer's disease","volume":"140","author":"Shinohara","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2018.10.003_bb0350","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00401-014-1287-x","article-title":"Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer's disease","volume":"127","author":"Bayer","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0355","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: the role of inflammation in Alzheimer disease","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2018.10.003_bb0360","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in Alzheimer's disease","volume":"16","author":"Heneka","year":"2015","journal-title":"Nat. Immunol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918303806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918303806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T15:12:28Z","timestamp":1575299548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443918303806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":72,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0925443918303806"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.10.003","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C-terminal truncation exacerbates the aggregation and cytotoxicity of \u03b1-Synuclein: A vicious cycle in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}